AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor.[1] It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.
Get access to your Orders, Wishlist and Recommendations.
Signup
Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy.